The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...

The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to suicide among users of ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...

Off-label medication-drugs FDA-approved to treat one condition but often prescribed for another-are changing the game for ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

What began as a powder scooped into smoothies and sold as a “natural supplement” is now drawing the attention of coroners, doctors and lawmakers across South Carolina.

Questions about cost and patient benefit loom as Congress considers automatic Medicare coverage for 'breakthrough' medical ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

The U.S. Food and Drug Administration has extended its review for the expanded ​use of Travere Therapeutics’ drug to treat a ...

Medication adherence packaging is no longer a “nice to have," it’s becoming a core component of modern healthcare delivery.